These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16034483)

  • 1. The involvement of glutamate in the pathophysiology of depression.
    Palucha A; Pilc A
    Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
    Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
    Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of low-frequency-induced synaptic depression in the developing CA3-CA1 hippocampal synapses by NMDA and metabotropic glutamate receptor activation.
    Strandberg J; Wasling P; Gustafsson B
    J Neurophysiol; 2009 May; 101(5):2252-62. PubMed ID: 19225168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.
    Kos T; Legutko B; Danysz W; Samoriski G; Popik P
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1128-36. PubMed ID: 16740621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor 1 activity generates persistent, N-methyl-D-aspartate receptor-dependent depression of hippocampal pyramidal cell excitability.
    Clement JP; Randall AD; Brown JT
    Eur J Neurosci; 2009 Jun; 29(12):2347-62. PubMed ID: 19490024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence.
    Caruso C; Durand D; Watanobe H; Lasaga M
    Neurosci Lett; 2006 Jan; 393(1):60-4. PubMed ID: 16226374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for AMPA receptors in mood disorders.
    Alt A; Nisenbaum ES; Bleakman D; Witkin JM
    Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
    Senkowska A; Ossowska K
    Pol J Pharmacol; 2003; 55(6):935-50. PubMed ID: 14730087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-based antidepressants: preclinical psychopharmacology.
    Pilc A; Wierońska JM; Skolnick P
    Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metabotropic glutamate receptors in the control of neuroendocrine function.
    Durand D; Pampillo M; Caruso C; Lasaga M
    Neuropharmacology; 2008 Sep; 55(4):577-83. PubMed ID: 18616955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate-based antidepressants: 20 years on.
    Skolnick P; Popik P; Trullas R
    Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptors modulate the NMDA- and AMPA-induced gene expression in neocortical interneurons.
    Lindemeyer K; Leemhuis J; Löffler S; Grass N; Nörenberg W; Meyer DK
    Cereb Cortex; 2006 Nov; 16(11):1662-77. PubMed ID: 16407481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonists of ionotropic glutamate receptors as the object of research in psychopharmacology].
    Bespalov AIu; Evartau EE
    Usp Fiziol Nauk; 1999; 30(1):39-53. PubMed ID: 10205818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern aspects of investigation and clinical application of glutamatergic agents].
    Petrov VI; Onishchenko NV
    Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible involvement of metabotropic glutamate receptors in schizophrenia.
    Krivoy A; Fischel T; Weizman A
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):395-405. PubMed ID: 18063347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate as a therapeutic target in psychiatric disorders.
    Javitt DC
    Mol Psychiatry; 2004 Nov; 9(11):984-97, 979. PubMed ID: 15278097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.